Xylem Inc

XYL: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|gGLOCK|<pHF@LOCK|Fn@?qR

Xylem Earnings: 2025 Outlook Raised as All Four Segments Deliver Strong Revenue Growth

Xylem's second-quarter adjusted EPS of $1.26 easily beat the FactSet consensus estimate by $0.11. Management raised its 2025 guidance and now anticipates full-year adjusted EPS of $4.70-$4.85, up from $4.50-$4.70 previously.

Sponsor Center